Type 1 diabetes prevention: Insulin vaccine undergoes second trial

5 octubre 2015

A vaccination against type 1 diabetes may soon be available to young children: the Pre-POINTearly vaccination study will involve children between the ages of six months and two years from across Germany who have a first-degree relative with type 1 diabetes. In the preceding Pre-POINT study a positive immune response was triggered in children aged between two and seven years with the aid of powdered insulin. The follow-up Pre-POINTearly study will now test whether this effect can be confirmed by giving very young children oral insulin, and whether type 1 diabetes can be prevented in the long term.
http://www.sciencedaily.com/releases/2015/10/151005080704.htm

Volver